3.9 Article

Quality and Performance Indicators in an Academic Department of Head and Neck Surgery

Journal

ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
Volume 136, Issue 12, Pages 1212-1218

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archoto.2010.215

Keywords

-

Funding

  1. NCI NIH HHS [P30 CA016672] Funding Source: Medline

Ask authors/readers for more resources

Objective: To create a method for assessing physician performance and care outcomes that are adjusted for procedure acuity and patient comorbidity. Design: Between 2004 and 2008 surgical procedures performed by 10 surgeons were stratified into high-acuity procedures (HAPs) and low-acuity procedures (LAPs). Risk adjustment was made for comorbid conditions examined singly or in groups of 2 or more. Setting: A tertiary care medical center. Patients: A total of 2618 surgical patients. Main Outcome Measures: Performance measures included length of stay; return to operating room within 7 days of surgery; and the occurrence of mortality, hospital readmission, transfusion, and wound infection within 30 days of surgery. Results: The transfusion rate was 2.7% and 40.6% for LAPs and HAPs, respectively. Wound infection rates were 1.4% for LAPs vs 14.1% for HAPs, while 30-day mortality rate was 0.3% and 1.6% for LAPs and HAPs, respectively. The mean (SD) hospital stay for LAPs was 2.1 (3.6) vs 10.5 (7.0) days for HAPs. Negative performance factors were significantly higher for patients who underwent HAPs and had comorbid conditions. Differences among surgeons significantly affect the incidence of negative performance indicators. Factors affecting performance measures were procedure acuity, the surgeon, and comorbidity, in order of decreasing significance. Surgeons were ranked low, middle, and high based on negative performance indicators. Conclusions: Performance measures following oncologic procedures were significantly affected by comorbid conditions and by procedure acuity. Although the latter most strongly affects quality and performance indicators, both should weigh heavily in physician comparisons. The incidence of negative performance indicators was also influenced by the individual surgeon. These data may serve as a tool to evaluate and improve physician performance and outcomes and to develop risk-adjusted benchmarks. Ultimately, reimbursement may be tied to quantifiable measures of physician and institutional performance. Arch Otolaryngol Head Neck Surg. 2010;136(12):1212-1218

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial

Mohamed A. M. Meheissen, Abdallah S. R. Mohamed, Mona Kama, Mike Hernande, Stefania Volpe, Hesham Elhalawani, Martha P. Barrow, Yao Ding, Jihong Wang, Raj Davuluri, Yousri Rostom, Neamat Hegazy, G. Brandon Gunn, Stephen Y. Lai, Adam S. Garden, Jan S. Lewin, David Rosenthal, Steven J. Frank, Clifton D. Fuller, Katherine A. Hutcheson

RADIOTHERAPY AND ONCOLOGY (2019)

Article Medicine, Research & Experimental

Outcomes of Carotid-Sparing IMRT for T1 Glottic Cancer: Comparison With Conventional Radiation

Abdallah S. R. Mohamed, Blaine D. Smith, Joshua B. Smith, Parag Sevak, Jessica S. Malek, Aasheesh Kanwar, Theodora Browne, G. Brandon Gunn, Adam S. Garden, Steven J. Frank, William H. Morrison, Jack Phan, Mark Zafereo, Heath Skinner, Stephen Y. Lai, Katherine A. Hutcheson, Jan S. Lewin, Amy E. Hessel, Apurva A. Thekdi, Randal S. Weber, Clifton D. Fuller, David I. Rosenthal

LARYNGOSCOPE (2020)

Review Otorhinolaryngology

Serious immune-related adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review

Mohsin Shah, Mona K. Jomaa, Renata Ferrarotto, Sai-Ching J. Yeung, Ehab Y. Hanna, Cielito C. Reyes-Gibby

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)

Article Otorhinolaryngology

Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic

Anastasios Maniakas, Yelda Jozaghi, Mark E. Zafereo, Erich M. Sturgis, Shirley Y. Su, Ann M. Gillenwater, Paul W. Gidley, Carol M. Lewis, Eduardo Diaz, Ryan P. Goepfert, Michael E. Kupferman, Neil D. Gross, Amy C. Hessel, Kristen B. Pytynia, Marc-Elie Nader, Jennifer R. Wang, Miriam N. Lango, Kimberley L. Kiong, Theresa Guo, Xiao Zhao, Christopher M. K. L. Yao, Eric Appelbaum, Jennifer Alpard, Jose A. Garcia, Shawn Terry, Jill E. Flynn, Sarah Bauer, Danielle Fournier, Courtlyn G. Burgess, Cayla Wideman, Matthew Johnston, Chenxi You, Rolando De Luna, Liza Joseph, Julia Diersing, Kaitlin Prescott, Katherine Heiberger, Lilian Mugartegui, Jessica Rodriguez, Sara Zendehdel, Justin Sellers, Rebekah A. Friddell, Ajay Thomas, Sonam J. Khanjae, Katherine B. Schwarzlose, Mark S. Chambers, Theresa M. Hofstede, Richard C. Cardoso, Ruth Aponte Wesson, Alex Won, Adegbenga O. Otun, Dan S. Gombos, Nagham Al-Zubidi, Katherine A. Hutcheson, G. Brandon Gunn, David Rosenthal, Maura L. Gillison, Renata Ferrarotto, Randal S. Weber, Ehab Y. Hanna, Jeffrey N. Myers, Stephen Y. Lai

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)

Article Oncology

Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy

Dario Pasalic, Ethan B. Ludmir, Pamela K. Allen, Nikhil G. Thaker, Bhavana V. Chapman, Ehab Y. Hanna, Shirley Y. Su, Renata Ferrarotto, Bonnie S. Glisson, Jay P. Reddy, G. Brandon Gunn, C. David Fuller, Jack Phan, David I. Rosenthal, William H. Morrison, Adam S. Garden, Steven J. Frank

RADIOTHERAPY AND ONCOLOGY (2020)

Article Oncology

Development and application of an elastic net logistic regression model to investigate the impact of cardiac substructure dose on radiation-induced pericardial effusion in patients with NSCLC

Joshua S. Niedzielski, Xiong Wei, Ting Xu, Daniel R. Gomez, Zhongxing Liao, James A. Bankson, Stephen Y. Lai, Laurence E. Court, Jinzhong Yang

ACTA ONCOLOGICA (2020)

Article Oncology

Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center

Richard C. Cardoso, Mona Kamal, Jhankruti Zaveri, Mark S. Chambers, G. Brandon Gunn, Clifton D. Fuller, Stephen Y. Lai, Frank E. Mott, Holly McMillan, Katherine A. Hutcheson

Summary: The study found a 31% prevalence of self-reported trismus, with severity correlating with quality of life and dysphagia. Trismus severity was negatively associated with T-stage, nodal stage, tumor sub-site, and concurrent chemoradiation.

SUPPORTIVE CARE IN CANCER (2021)

Letter Oncology

Surgical Perspective on Sentinel Node Biopsy for Operable T1-T2N0 Oral and Oropharyngeal Cancer Reply

Stephen Y. Lai, Robert L. Ferris

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel

Anton S. Becker, Rocio Perez-Johnston, Sona A. Chikarmane, Melissa M. Chen, Maria El Homsi, Kimberly N. Feigin, Katherine M. Gallagher, Ehab Y. Hanna, Marshall Hicks, Ahmet T. Ilica, Erica L. Mayer, Atul B. Shinagare, Randy Yeh, Marius E. Mayerhoefer, Hedvig Hricak, H. Alberto Vargas

Summary: Vaccination-associated adenopathy is a common imaging finding after COVID-19 vaccination, which may be mistaken for malignant nodal involvement in patients with cancer. Routine imaging should be scheduled at least 6 weeks after vaccination, while clinically indicated imaging should not be delayed.

RADIOLOGY (2021)

Article Oncology

The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry

Lisanne V. van Dijk, Abdallah S. R. Mohamed, Renata Ferrarotto, Lance A. McCoy, Christina S. Sharafi, Eva Jones, Kennedy Steele, Amy C. Moreno, Stephen Y. Lai, Adam S. Garden, Jeffrey N. Myers, David I. Rosenthal, Clifton D. Fuller, Katherine A. Hutcheson

Summary: Chemotherapy in addition to radiotherapy for oropharyngeal cancer patients can lead to significantly worse acute symptom outcomes compared to radiotherapy alone, especially during treatment. However, symptoms tend to attenuate in the late post-treatment period, with induction chemotherapy specifically associated with worse numbness and shortness of breath during and after treatment.

CANCER (2021)

Review Otorhinolaryngology

Role of sentinel lymph node biopsy for oral squamous cell carcinoma: Current evidence and future challenges

Sophie S. Jang, Morgan E. Davis, David R. Vera, Stephen Y. Lai, Theresa W. Guo

Summary: Sentinel lymph node biopsy has potential clinical utility in the treatment of early stage oral cavity squamous cell carcinoma, but its application should be evaluated in conjunction with factors such as depth of invasion, nodal mapping, and histopathology methods.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2023)

Article Oncology

The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry

Lisanne van Dijk, Abdallah S. R. Mohamed, Renata Ferrarotto, Lance A. McCoy, Christina S. Sharafi, Eva Jones, Kennedy Steele, Amy C. Moreno, Stephen Y. Lai, Adam S. Garden, Jeffrey N. Myers, David Rosenthal, Clifton D. Fuller, Katherine A. Hutcheson

Summary: The study found that patients with oropharyngeal cancer who received chemotherapy in addition to radiotherapy had more severe acute symptoms compared to those who only received radiotherapy, but the symptoms seemed to improve in the late post-treatment period. Induction chemotherapy was specifically associated with worse numbness and shortness of breath symptoms.

CANCER (2021)

Article Medicine, General & Internal

Ultra-small superparamagnetic iron oxide (USPIO) magnetic resonance imaging in benign mixed tumor of the parotid gland

Jason M. Johnson, Abdallah S. R. Mohamed, Yao Ding, Jihong Wang, Stephen Y. Lai, Clifton D. Fuller, Rutvij Shah, Randall T. Butler, Randal S. Weber

Summary: Historically, USPIO has been used for nodal staging, not primary tumors. The ability to concentrate USPIO may aid in differentiating BMT from other parotid tumors.

CLINICAL CASE REPORTS (2021)

Letter Medicine, General & Internal

Head and Neck Cancer

Ewe-Seng Ch'ng

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Oncology

Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive

Yitan Zhu, Abdallah S. R. Mohamed, Stephen Y. Lai, Shengjie Yang, Aasheesh Kanwar, Lin Wei, Mona Kamal, Subhajit Sengupta, Hesham Elhalawani, Heath Skinner, Dennis S. Mackin, Jay Shiao, Jay Messer, Andrew Wong, Yao Ding, Lifei Zhang, Laurence Court, Yuan Ji, Clifton D. Fuller

JCO CLINICAL CANCER INFORMATICS (2019)

No Data Available